vs

Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and EMERSON RADIO CORP (MSN). Click either name above to swap in a different company.

EMERSON RADIO CORP is the larger business by last-quarter revenue ($1.9M vs $1.1M, roughly 1.7× Insight Molecular Diagnostics Inc.). EMERSON RADIO CORP runs the higher net margin — -36.7% vs -2015.4%, a 1978.7% gap on every dollar of revenue. On growth, Insight Molecular Diagnostics Inc. posted the faster year-over-year revenue change (-23.4% vs -52.8%). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -7.3%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Emerson Radio Corporation is one of the United States' largest volume consumer electronics distributors and has a recognized trademark in continuous use since 1912. The company designs, markets, and licenses many product lines worldwide, including products sold, and sometimes licensed, under the brand name G Clef, an homage to Emerson's logo.

IMDX vs MSN — Head-to-Head

Bigger by revenue
MSN
MSN
1.7× larger
MSN
$1.9M
$1.1M
IMDX
Growing faster (revenue YoY)
IMDX
IMDX
+29.4% gap
IMDX
-23.4%
-52.8%
MSN
Higher net margin
MSN
MSN
1978.7% more per $
MSN
-36.7%
-2015.4%
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
-7.3%
MSN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IMDX
IMDX
MSN
MSN
Revenue
$1.1M
$1.9M
Net Profit
$-23.0M
$-694.0K
Gross Margin
42.5%
10.9%
Operating Margin
-2057.5%
-43.7%
Net Margin
-2015.4%
-36.7%
Revenue YoY
-23.4%
-52.8%
Net Profit YoY
31.5%
-31.7%
EPS (diluted)
$-0.75
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMDX
IMDX
MSN
MSN
Q4 25
$1.1M
$1.9M
Q3 25
$260.0K
$1.2M
Q2 25
$518.0K
$1.7M
Q1 25
$2.1M
$1.8M
Q4 24
$1.5M
$4.0M
Q3 24
$115.0K
$2.7M
Q2 24
$104.0K
$2.2M
Q1 24
$176.0K
$2.2M
Net Profit
IMDX
IMDX
MSN
MSN
Q4 25
$-23.0M
$-694.0K
Q3 25
$-10.9M
$-1.0M
Q2 25
$-9.7M
$-1.1M
Q1 25
$-6.7M
$-2.4M
Q4 24
$-33.5M
$-527.0K
Q3 24
$-13.5M
$-881.0K
Q2 24
$-4.5M
$-962.0K
Q1 24
$-9.1M
$-883.0K
Gross Margin
IMDX
IMDX
MSN
MSN
Q4 25
42.5%
10.9%
Q3 25
53.5%
-0.1%
Q2 25
67.6%
0.7%
Q1 25
62.0%
-3.0%
Q4 24
40.0%
12.3%
Q3 24
43.5%
9.9%
Q2 24
48.1%
8.8%
Q1 24
25.6%
15.9%
Operating Margin
IMDX
IMDX
MSN
MSN
Q4 25
-2057.5%
-43.7%
Q3 25
-4249.2%
-98.4%
Q2 25
-1900.0%
-78.1%
Q1 25
-318.0%
-137.8%
Q4 24
-2262.9%
-18.3%
Q3 24
-11752.2%
-40.8%
Q2 24
-4453.8%
-55.6%
Q1 24
-5265.3%
-52.2%
Net Margin
IMDX
IMDX
MSN
MSN
Q4 25
-2015.4%
-36.7%
Q3 25
-4174.6%
-85.8%
Q2 25
-1880.7%
-68.1%
Q1 25
-312.0%
-127.9%
Q4 24
-2255.1%
-13.2%
Q3 24
-11733.0%
-32.2%
Q2 24
-4355.8%
-43.8%
Q1 24
-5186.9%
-40.1%
EPS (diluted)
IMDX
IMDX
MSN
MSN
Q4 25
$-0.75
$-0.03
Q3 25
$-0.34
$-0.05
Q2 25
$-0.30
$-0.05
Q1 25
$-0.26
$-0.10
Q4 24
$-2.19
$-0.03
Q3 24
$-0.98
$-0.04
Q2 24
$-0.36
$-0.05
Q1 24
$-1.13
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMDX
IMDX
MSN
MSN
Cash + ST InvestmentsLiquidity on hand
$11.6M
$13.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-31.5M
$18.6M
Total Assets
$25.8M
$20.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMDX
IMDX
MSN
MSN
Q4 25
$11.6M
$13.3M
Q3 25
$18.7M
$13.5M
Q2 25
$24.3M
$15.5M
Q1 25
$31.0M
$16.1M
Q4 24
$8.6M
$16.4M
Q3 24
$3.4M
$16.7M
Q2 24
$9.3M
$18.9M
Q1 24
$5.6M
$19.9M
Stockholders' Equity
IMDX
IMDX
MSN
MSN
Q4 25
$-31.5M
$18.6M
Q3 25
$-9.2M
$19.3M
Q2 25
$1.1M
$20.4M
Q1 25
$10.2M
$21.5M
Q4 24
$-12.3M
$23.9M
Q3 24
$9.7M
$24.4M
Q2 24
$22.7M
$25.3M
Q1 24
$11.6M
$26.2M
Total Assets
IMDX
IMDX
MSN
MSN
Q4 25
$25.8M
$20.1M
Q3 25
$43.9M
$20.7M
Q2 25
$50.5M
$23.3M
Q1 25
$60.4M
$23.5M
Q4 24
$35.1M
$26.4M
Q3 24
$70.2M
$26.6M
Q2 24
$74.7M
$28.5M
Q1 24
$71.0M
$29.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMDX
IMDX
MSN
MSN
Operating Cash FlowLast quarter
$-5.5M
$-228.0K
Free Cash FlowOCF − Capex
$-7.0M
FCF MarginFCF / Revenue
-616.7%
Capex IntensityCapex / Revenue
129.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMDX
IMDX
MSN
MSN
Q4 25
$-5.5M
$-228.0K
Q3 25
$-4.5M
$-2.0M
Q2 25
$-6.3M
$-514.0K
Q1 25
$-5.9M
$-391.0K
Q4 24
$-5.4M
$-293.0K
Q3 24
$-5.5M
$-2.1M
Q2 24
$-6.0M
$-840.0K
Q1 24
$-3.8M
$-2.2M
Free Cash Flow
IMDX
IMDX
MSN
MSN
Q4 25
$-7.0M
Q3 25
$-5.6M
Q2 25
$-6.6M
Q1 25
$-6.2M
Q4 24
$-5.6M
$-301.0K
Q3 24
$-5.6M
$-2.1M
Q2 24
$-6.2M
$-1.0M
Q1 24
$-3.9M
$-2.3M
FCF Margin
IMDX
IMDX
MSN
MSN
Q4 25
-616.7%
Q3 25
-2135.4%
Q2 25
-1279.5%
Q1 25
-288.4%
Q4 24
-374.5%
-7.5%
Q3 24
-4884.3%
-77.8%
Q2 24
-5931.7%
-46.4%
Q1 24
-2189.8%
-102.3%
Capex Intensity
IMDX
IMDX
MSN
MSN
Q4 25
129.9%
0.0%
Q3 25
403.8%
0.0%
Q2 25
67.4%
0.0%
Q1 25
14.4%
0.0%
Q4 24
14.4%
0.2%
Q3 24
75.7%
0.3%
Q2 24
183.7%
8.2%
Q1 24
13.6%
0.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMDX
IMDX

Segment breakdown not available.

MSN
MSN

Products$1.8M95%
Other$87.0K5%

Related Comparisons